Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
BJU Int. 2010 Jul;106(1):53-5. doi: 10.1111/j.1464-410X.2009.09119.x. Epub 2009 Dec 11.
Diagnosis (exploratory cohort) Level of Evidence 2b.
To assess individual urologist variability using narrow-band imaging (NBI) cystoscopy to evaluate bladder tumours.
In all, 50 patients underwent white-light and NBI cystoscopy to evaluate for recurrent bladder tumours. Endoscopic images in each patient were independently viewed by four urologists assessing presence or absence of tumour. Their findings were correlated with biopsy results.
In all, 26 patients had recurrent tumour and 24 had benign histology. There were no significant differences among urologists detecting recurrent tumour or in determining final pathology.
There does not appear to be a 'learning curve' for adapting to NBI-surveillance cystoscopy in patients with bladder cancer.
诊断(探索性队列)证据水平 2b。
使用窄带成像(NBI)膀胱镜检查评估膀胱癌,以评估单个泌尿科医生的变异性。
共有 50 例患者接受了白光和 NBI 膀胱镜检查,以评估复发性膀胱肿瘤。每位患者的内镜图像均由 4 名泌尿科医生独立观察,评估是否存在肿瘤。他们的发现与活检结果相关。
共有 26 例患者有复发性肿瘤,24 例患者有良性组织学。在检测复发性肿瘤或确定最终病理方面,泌尿科医生之间没有显著差异。
在膀胱癌患者中,似乎没有适应 NBI 监测膀胱镜检查的“学习曲线”。